Resource Tag: Accelerate Use of Real-World Data & Evidence
Patient Listening on Social Media for Patient-Focused Drug Development.
Patients, life science industry and regulatory authorities are united in their goal to reduce the disease burden of patients by closing remaining unmet needs. Patients have, however, not always been systematically and consistently involved in the drug development process. Recognizing this gap, regulatory bodies worldwide have initiated patient-focused drug development (PFDD) initiatives to foster a more systematic involvement of patients in the drug development process and to ensure that outcomes measured in clinical trials are truly relevant to patients and represent significant improvements to their quality of life.
Patient Listening on Social Media for Patient-Focused Drug Development
A synthesis of considerations from patients, industry and regulators
Strategic Priorities Update February 2024
Join us for this inaugural update on the newly formed Strategic Priorities of the Pistoia Alliance, followed by a 30 minutes Q&A with our panelists
Agenda
Dr Becky Upton, President of the Pistoia Alliance
- Introduction
Dr Christian Baber, Chief Portfolio Officer, Pistoia Alliance
- Strategic Priorities Overview
- Harnessing AI to Expedite R&D
- Delivering Data-Driven Value
Thierry Escudier, Portfolio Lead, Pistoia Alliance
- Accelerating Use of Real-World Data
- Sustainability Driven R&D
An extension of the BioAssay Ontology
An extension of the BioAssay Ontology to now include pharmacokinetic/pharmacodynamic terminology for the enrichment of scientific workflows
Medical Research Charities and Biopharmaceutical Companies as Partners in Patient-Centred R&D
The Pistoia Alliance gathered a number of UK MRCs focused on complex lifelong conditions. The group used workshops and an opinion questionnaire for a snapshot of how the charities believe their knowledge and patient experiences could contribute insights and efficiencies to commercial R&D.
Calls for life sciences to focus on patient centricity
The life sciences and healthcare industries should restructure around patient centricity, according to global not-for-profit the Pistoia Alliance.
The call follows a meeting at the Pistoia Alliance’s annual European conference in London where discussions around the sector’s position in the wake of the Covid-19 pandemic took place. Attendees at the meeting highlighted how advances in technology are helping patients become more empowered regarding their health.